Abstract:Background: TIM-4, the only TIM protein not expressed on T cells, is found on macrophages and dendritic cells. As an innate immunity-driven local inflammation response, we hypothesized that TIM-4 signaling may play a role in the mechanism of liver IRI. Methods&Results: Unlike in sham controls, the ischemia insult triggered TIM-4 mRNA expression in mouse livers subjected to warm ischemia (90min) and reperfusion (0-24h). Its levels increased progressively, peaking by 6h of reperfusion, and declining at 12-24h. TIM-4 expression correlated with the kinetics of hepatocellular damage (sALT levels), and macrophage infiltration/activation, both peaking at 6h of reperfusion. Indeed, TIM-4 KO or WT (B/6) mice treated with antagonistic TIM-4 mAb (RMT4-53; 0.5 mg i.v. at -1h) were resistant against liver IRI, as shown by sALT levels, hepatic architecture (no edema, vacuolization/necrosis), and Suzuki’s histological score. Unlike in controls, TIM-4 blockade/ablation decreased hepatic CD68+ macrophage sequestration. Although TLR2, TLR4, and TLR9 were all induced in Ig-treated IR-stressed livers, their levels were suppressed in TIM-4 KO groups, along with diminished pro-inflammatory cytokines (TNF-α, IL-1β, and IL-6). To document the function of TIM-4+ macrophages, we have developed a new model of liver IRI in which CD11b-DTR mice were adoptively transferred with syngeneic bone marrow macrophages (BMM; 5×106 cells i.v. at day -1). After DT treatment at day -2 (circulating CD11b <0.2%), CD11b-DTR mice remained uniformly IR-resistant, compared with PBS-controls. Interestingly, unlike WT BMM, which recreated liver IRI after adoptive transfer in CD11b-DTR test mice, infusion of TIM-4-deficient BMM failed to trigger IRI, as shown by diminished sALT levels, well-preserved liver architecture, and decreased Suzuki’s histological score. Of note, consistently heightened TNF-α, IL-1β, and IL-6 levels in CD11b-DTR mice repopulated with TIM-4 proficient (WT) BMM were diminished after infusion of TIM-4 deficient (KO) BMM. Conclusion: This study provides new evidence that: 1) IR-stressed liver macrophages express TIM-4; 2) Disruption of TIM-4 signaling ameliorates liver IRI; and 3) TIM-4 signaling is critically required for macrophage activation in the mechanism of liver IR-damage. Hence, modulation of physiological TIM-4 expression provides the basis for novel therapeutic strategies against organ IRI in transplant recipients.

TIMP-1 Promotes Expression of MCP-1 and Macrophage Migration by Inducing Fli-1 in Experimental Liver Fibrosis

Mir-301A-3p Promotes Hepatic Stellate Cells Activation and Liver Fibrogenesis Via Regulating PTEN/PDGFR-β.

Tissue inhibitor of metalloproteinases-1 promotes liver fibrosis development in a transgenic mouse model

MiR-542-3p controls hepatic stellate cell activation and fibrosis via targeting BMP-7.

MicroRNA-146b Regulates Hepatic Stellate Cell Activation Via Targeting of KLF4.

Tissue Inhibitor of Metalloproteinase 1 (TIMP-1) Deficiency Exacerbates Carbon Tetrachloride-Induced Liver Injury and Fibrosis in Mice: Involvement of Hepatocyte STAT3 in TIMP-1 Production

Effects of Antisense Tissue Imhibitor of Metalloproteinase-1 Expressing Plasmid on Porcine Serum-Induced Rat Liver Fibrosis

T-Cell Immunoglobulin and Mucin Domain 4 (Tim-4) Signaling in Innate Immune-Mediated Liver Ischemia-Reperfusion Injury (Iri)

Targeting Tissue Inhibitor Of Metalloproteinase 1/2 Using A Shrna Lentiviral System Offers A Novel Treatment Strategy Against Hepatic Fibrosis

Characterization of the MMP/TIMP Imbalance and Collagen Production Induced by IL-1β or TNF-α Release from Human Hepatic Stellate Cells

FSTL1 promotes liver fibrosis by reprogramming macrophage function through modulating the intracellular function of PKM2

Timp-1 Activated Carcinoma-Associated Fibroblasts Inhibit Tumor Apoptosis by Activating Sdf1/Cxcr4 Signaling in Hepatocellular Carcinoma

MicroRNA-708 Modulates Hepatic Stellate Cells Activation and Enhances Extracellular Matrix Accumulation Via Direct Targeting TMEM88.

TIMP-1 Expression Induced by IL-32 is Mediated Through Activation of AP-1 Signal Pathway.

Mir-20A-5p/tgfbr2 Axis Affects Pro-inflammatory Macrophages and Aggravates Liver Fibrosis.

miR-140-5p attenuates hepatic fibrosis by directly targeting TGFβR1

MCPIP1 Inhibits Hepatic Stellate Cell Activation in Autocrine and Paracrine Manners, Preventing Liver Fibrosis

Increased Tim-3 expression alleviates liver injury by regulating macrophage activation in MCD-induced NASH mice

Levocarnitine regulates the growth of angiotensin II-induced myocardial fibrosis cells via TIMP-1

Modified Synthetic Sirna Targeting Tissue Inhibitor of Metalloproteinase‐2 Inhibits Hepatic Fibrogenesis in Rats